Oligonucleotide Therapy Market Trends | 15.8% CAGR Fueled by Oncology & Neurology Innovations | DataM Intelligence
Oligonucleotide Therapy Market grows from $6.53 Billion (2024) to $24.46 Billion (2033) at 15.8% CAGR, driven by rare diseases & FDA approvals. AUSTIN, TX, UNITED STATES, September 1, 2025 /EINPresswire.com/ -- The oligonucleotide therapy market is …